Jenne Kyle bought IONS
March 10, 2026 · Form 4 insider transaction
Jenne Kyle bought 32,602 shares of Ionis Pharmaceuticals, Inc. at $46.10 per share, a transaction worth $1.50M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
32,602
Price
$46.10
Total value
$1.50M
InsiderJenne Kyle
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 10, 2026
Filing dateMarch 11, 2026
Shares owned after48,991
OwnershipDirect
10b5-1 planNo
AmendedNo